• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY PROMUS ELEMENT¿ PLUS; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Model Number H7493911408250
Device Problem Occlusion Within Device (1423)
Patient Problems Atrial Fibrillation (1729); Chest Pain (1776); Non specific EKG/ECG Changes (1817); Cardiac Enzyme Elevation (1838); Myocardial Infarction (1969); Reocclusion (1985); Obstruction/Occlusion (2422)
Event Date 04/18/2015
Event Type  Injury  
Manufacturer Narrative
Device is a combination product.Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Event Description
Same case as mdr id#: 2134265-2017-00299.(b)(4) clinical study.It was reported that in-stent restenosis (isr) and non-st segment elevation myocardial infarction (nstemi) occurred.In (b)(6) 2013, index procedure was performed.Target lesion was a de novo lesion located in the mid left anterior descending artery (lad) with 80% stenosis and was 22 mm long with a reference vessel diameter of 2.75 mm.Target lesion was treated with pre-dilatation and placement of a 2.50 mm x 16 mm and 2.50 mm x 8 mm promus element¿ plus drug-eluting stents (des) in overlapping manner.Following post dilatation residual stenosis was 0%.The following day, the patient was discharged on aspirin and prasugrel.In (b)(6) 2015, the patient presented to the emergency department (ed) with the complaint of chest pain.The patient described the pain as a tight sub sternal pressure that radiates to both shoulders with associated shortness of breath.Electrocardiogram (ecg) revealed atrial fibrillation with rapid ventricular response; anterolateral st-t changes are nonspecific.On the same day, cardiac enzymes were noted to be elevated.The elevated level of cardiac enzyme along with ecg changes suggested acute ischemia and the site has reported an event of nstemi.The patient was started on iv heparin and nitroglycerin drip for nstemi and was referred for cardiac catheterization.The next day, a 99% isr of the middle of the stents in the mid portion with a very sluggish flow and a mild 30% stenosis in the mid segment of the 2nd diagonal were noted.The 99% isr located in mid lad was treated with pre-dilatation and placement of 2.5 mm x 26 mm, 3.00 mm x 22 mm and 3.00 mm x 22 mm non-bsc des in overlapping manner with 0% residual stenosis.The following day, the event was considered as resolved and the patient was discharged on aspirin and prasugrel.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROMUS ELEMENT¿ PLUS
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6278663
MDR Text Key65767592
Report Number2134265-2017-00300
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110010
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 01/06/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/30/2013
Device Model NumberH7493911408250
Device Catalogue Number39114-0825
Device Lot Number0015513222
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/06/2017
Initial Date FDA Received01/26/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured09/17/2012
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age71 YR
-
-